VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BigKNY3 who wrote (4768)	1/19/1998 9:42:00 AM
From: Tunica Albuginea	Read Replies (2) of 23519

BigKNY3, you need to be more accurate then that. I say ALL of PFEs products can be substituted. -Procardia can be sub'd with Adalat and others. -Norvasc can be replaced by Adalat.In my hospital none ( largest cardiac cases in the state ) nobody is beating the drum to Norcasc. plain Adalat will do. -Trovan soon to come out. There are 6 other quinolones that will be more competitively priced in market. -Zithropak. This can safely be substituted with a cheaper quinolone or another Erythromycin. These are some I can remember. bring out any drug and I will show you a replacement. - " Not many physicians are willing to substitute Zoloft with one of the cheaper antidepressant". When Aetna goes from 115 to $70? share as well as Oxford Health plans , Prudential etc, the docs over there will be told in no uncertain terms that " their prescribing habits are tooo expensive" and thus " will hire somebody else In the case of Zoloft for example, most antidepressants today are prescribed not for their primary indication - endogenous depression- but for exogenous depression: people depressed for loss of somehting, etc Zoloft / tricyclics are totally useless. Docs are going to have to learn to live within a budget just like the rest of us including uncle Sam. Again, the 40 year gravy train in HMO growth ( fueled by lavish consumer taxation, also known as " the shaft", is about to come to a grinding halt.Aetna will make sure that they stay in business no matter what.The next place to cut is drugs.PFE and the Drug stocks may be down even 50% if any threat to their future earnings is perceived. All in my opinion. TA PS there are several innacccuracies in your" Textbook report to Gene " yesterday. If nobody can get to them before me I'll get to them later.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next